1158392-64-3 Usage
Uses
Used in Pharmaceutical Research and Development:
1-Pyridin-3-ylMethyl-piperazine dihydrochloride is used as a research compound for exploring its potential therapeutic effects as an antipsychotic and anxiolytic agent. Its interactions with various receptors in the brain make it a promising candidate for the development of new medications to treat mental health disorders.
Used in Medicinal Chemistry Studies:
1-Pyridin-3-ylMethyl-piperazine dihydrochloride is used as a research tool in medicinal chemistry to investigate its interactions with the central nervous system. This helps scientists understand its mechanism of action and potential side effects, which is crucial for the development of safe and effective drugs.
Used as a Building Block in Pharmaceutical Synthesis:
Due to its unique chemical structure and properties, 1-Pyridin-3-ylMethyl-piperazine dihydrochloride is used as a building block in the synthesis of other pharmaceutical compounds. This allows for the creation of new drugs with potentially improved efficacy, safety, and pharmacokinetic profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 1158392-64-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,8,3,9 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1158392-64:
(9*1)+(8*1)+(7*5)+(6*8)+(5*3)+(4*9)+(3*2)+(2*6)+(1*4)=173
173 % 10 = 3
So 1158392-64-3 is a valid CAS Registry Number.
1158392-64-3Relevant academic research and scientific papers
COMPOUNDS FOR TREATING VIRAL INFECTIONS
-
, (2015/11/09)
The present invention relates to small molecule compounds and their use in the treatment of diseases, in particular viral diseases, in particular hepatitis C virus (HCV).
Aralkyl-alcohol peiperazine derivatives adn their uses as antidepressant
-
Page/Page column 7, (2008/06/13)
Aryl alkanol piperazine derivatives of the formula and pharmaceutical compositions comprising the same. Also disclosed are methods for treating depression using the pharmaceutical compositon. Compounds of the invention have excellent dual inhibitory actions to the uptake of the mono-amines neurotransmitter, good antidepressant activities and minor side effects.
